407 related articles for article (PubMed ID: 15978949)
21. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
[TBL] [Abstract][Full Text] [Related]
22. [Case with hairy cell leukemia-Japanese variant following radiotherapy for orbital adnexal MALT lymphoma].
Nakamura Y; Kayano H; Kakegawa E; Uchida Y; Shimada T; Wakimoto N; Ito Y; Bessho M
Rinsho Ketsueki; 2010 Nov; 51(11):1674-9. PubMed ID: 21157131
[TBL] [Abstract][Full Text] [Related]
23. Cladribine in hairy cell leukemia.
Belani R; Saven A
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
[TBL] [Abstract][Full Text] [Related]
24. The disease with hope: hairy cell leukemia.
Becker SE
Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
[TBL] [Abstract][Full Text] [Related]
25. [53-year old male with anemic syndrome, splenomegaly and pancytopenia (clinicopathologic conference)].
Giralt M; Feliu E
Med Clin (Barc); 1984 Dec; 83(20):859-65. PubMed ID: 6527588
[No Abstract] [Full Text] [Related]
26. A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis.
Hasselbalch H; Jans H; Nielsen PL
Am J Hematol; 1987 Jun; 25(2):225-9. PubMed ID: 3605072
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide therapy for myelofibrosis with myeloid metaplasia.
Thomas DA; Giles FJ; Albitar M; Cortes JE; Verstovsek S; Faderl S; O'Brien SM; Garcia-Manero G; Keating MJ; Pierce S; Zeldis J; Kantarjian HM
Cancer; 2006 May; 106(9):1974-84. PubMed ID: 16583431
[TBL] [Abstract][Full Text] [Related]
28. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
29. Variant hairy cell leukemia following papillary urothelial neoplasm of bladder.
Beyan C; Kaptan K
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S27-8. PubMed ID: 24717996
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.
Benetatos L; Chaidos A; Alymara V; Vassou A; Bourantas KL
Eur J Haematol; 2005 Mar; 74(3):273-4. PubMed ID: 15693801
[No Abstract] [Full Text] [Related]
31. Panuveitis responsive to 2-CdA: an unusual ocular presentation of hairy cell leukemia.
Zeidman A; Floru S; Robinson A; Polliack A; Djaldeti M; Savir H; Mittelman M
Leuk Lymphoma; 1996 Feb; 20(5-6):501-3. PubMed ID: 8833410
[TBL] [Abstract][Full Text] [Related]
32. [Hairy cell leukaemia with severe bone marrow insufficiency. Complete remission after chemotherapy in two patients (author's transl)].
Marty M; Calvo F; Castaigne S; Flandrin G
Nouv Presse Med; 1981 Oct; 10(36):2977-9. PubMed ID: 7290952
[TBL] [Abstract][Full Text] [Related]
33. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: clinical presentation and long term follow up after treatment with 2-chlorodeoxyadenosine (2-CdA).
Bilwani F; Usman M; Adil SN; Kakepoto GN; Khurshid M
J Pak Med Assoc; 2005 May; 55(5):212-3. PubMed ID: 15960289
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
Zinzani PL; Tani M; Marchi E; Stefoni V; Alinari L; Musuraca G; Gabriele A; Pileri S; Baccarani M
Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
[TBL] [Abstract][Full Text] [Related]
36. [A diagnostically difficult case of hairy cell leukemia with ring-shaped nuclei].
Lemez P; Friedmann B; Vanásek J; Bednár B
Sb Lek; 1991 Mar; 93(1-2):33-5. PubMed ID: 2047740
[TBL] [Abstract][Full Text] [Related]
37. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
[TBL] [Abstract][Full Text] [Related]
38. [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress].
Makita M; Nakamura K; Kono A
Rinsho Ketsueki; 2005 Nov; 46(11):1196-201. PubMed ID: 16440803
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic vasculitis associated with hairy cell leukemia.
Svecová D; Pallová A; Chmurová N; Babal P
Prague Med Rep; 2008; 109(1):83-7. PubMed ID: 19097393
[TBL] [Abstract][Full Text] [Related]
40. Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.
Berrebi A; Feldberg E; Spivak I; Shvidel L
Haematologica; 2007 Feb; 92(2):e15-6. PubMed ID: 17405746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
